You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
JavaScript Required
JavaScript is required to use content on this page. Please enable JavaScript in your browser.
Skip to Content
Accessibility Information
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Maryland Department of Health
Maternal and Child Health Bureau (MCHB)
Maternal and Child Health Bureau (MCHB)
Currently selected
Section Menu
Home
Currently selected
A-Z Index
Babies Born Healthy
Child and Adolescent Health
Child Maltreatment
Child Fatality Review
Children’s Medical Services Program
Early Hearing Detection and Intervention Program
Family Planning
Fetal and Infant Mortality Review
Infant Safe Sleep
Maternal and Perinatal Health Program
Maternal Mortality Review
Maternal, Infant, and early Childhood Home Visiting Program
MD WIC Program
Newborn BloodSpot Screening
Pregnancy Care and HIV, Syphilis & Hepatitis Prevention
Pregnancy Risk Assessment Monitoring System (PRAMS)
Postpartum Referral
School Health Guidance and Resources
Sickle Cell Disease and Trait Follow up Program
Title V MCH Block Grant
Urgent Warning Signs in Pregnancy and Postpartum
Women’s Health Action Plan
Women's Health
Other Links
Contact Us
Links and Related Resources
MCH Epidemiology
Medicaid Child Health Programs
Office of Children and Youth with Specific Health Care Needs
Office of Family and Community Health
Office of Quality Initiatives
Office of the Maryland WIC Program
What's New?
Where to Find Services
Left_Content
MCH HOTLINE
1-800-456-8900
Main_Content
Opioids
What are opioids?
Opioids include oral opiates like codeine, hydrocodone, oxycodone, fentanyl or meperidine as well as heroin, which can be smoked, used intra-nasally, or injected
1
Heroin is a synthetic opioid that is lipid soluble and crosses the blood-brain barrier where it is converted to morphine
Opioids work by binding to three types of opiate receptors throughout the body causing an analgesic effect resulting in increased pain tolerance and feelings of euphoria
2, 3
Side effects can include sedation, respiratory depression and decreased gastrointestinal function
2, 3
Prescription opioids are the most commonly abused prescription drugs in the U.S.
4
Heroin is the most commonly used non-prescription opioid in the U.S.
2
What are the medical consequences of opioid use?
Dependence
4
Overdose
1
Respiratory depression
4
Sedation
4
Liver disease
5
Kidney disease
5
Pulmonary disease like pneumonia, tuberculosis1
Chronic constipation
5
Withdrawal
4,5
Pain
1
Restlessness
1
Vomiting
1
Diarrhea
1
If injected risks include:
Increased risk of infection like HIV, HCV
5
Venous problems
5
What are the treatment options for opioid abuse?
There are multiple options for the treatment of opioid dependence in pregnancy including medical detoxification or medical maintenance with methadone or buprenorphine
6
What are the medical consequences of heroin use in pregnancy?
Placental abruption
7
Preterm labor
7
Fetal death
7
Decreased birth weight
8
Small head circumference
If heroin is used intravenously, the fetus and the mother are at increased risk of infections like HIV and hepatitis
7, 9
There is some evidence that prenatal exposure to heroin can cause babies to be irritable and difficult to console even in the weeks and months after birth
8
What are the medical consequences of prescription opioid use in pregnancy?
Inconsistent data is available regarding some of the fetal effects of prescription opioid use in pregnancy
Some studies have shown an increased risk of cleft lip and palate, cardiac defects, and gastroschisis with the use of oral opioids
1
However, other large trials have found no significant increase in risk of congenital malformations with use of opioids in the first trimester
Neonatal Abstinence Syndrome
Use of both prescription opioids and heroin is clearly associated with neonatal abstinence syndrome when the infant withdraws from opiates after the maternal source is removed
11
It us occurs within 1-10 days of delivery
2
The syndrome affects multiple organ systems including the brain, the GI tract, and the autonomic nervous system
1
Associated symptoms include:
Seizures
12
Poor feeding
12
Vomiting
12
Diarrhea
12
Excessive sweating
12
Fevers
12
Temperature instability
12
What are the treatment options for opioid abuse in pregnancy?
There are multiple options for the treatment of opioid dependence in pregnancy including medical detoxification or medical maintenance with methadone or buprenorphinebuprenorphine
6
Prior to the introduction of buprenorphine in 2002, the preferred treatment was with methadone as its use was associated with increased compliance and avoidance of repeated intoxication compared to detoxificationbuprenorphine
6
Multiple studies have examined the advantages of buprenorphine as compared to methadone6
While buprenorphine does appear to be associated with less neonatal abstinence syndrome, the two medications seem to be otherwise comparablebuprenorphine
6
Due to the changes in pharmacokinetics in pregnancy, the dose of methadone or buprenorphine may need to be increased as pregnancy continues
6, 7
Women who are on medical maintenance for opioid use should receive adequate analgesia during labor and delivery
6, 7
It is important to avoid narcotic agonist-antagonist medications during labor and delivery such as butorphanol, nalbuphine, and pentazocine as they can cause acute opioid withdrawal
7
Resources
Heroin: Abuse and Addiction.
Retrieved January 15, 2014 from The National Institute on Drug Abuse Web site:
http://www.drugabuse.gov/publications/research-reports/heroin-abuse-addiction
Stanhope, T.J. et al (2013).
Chronic opioid use during pregnancy: Maternal and fetal implications. Clin Perinatol 40. 337-350.
Lindsay, M.K. and Burnett, E. (2013). The use of narcotic and street drugs during pregnancy. Clinical Obstetrics and Gynecology 56. 133-141.
American College of Obstetricians and Gynecologists. (2012).
ACOG Committee Opinion 538: Non-medical Use of Prescription Drugs.
Washington, DC: American College of Obstetricians and Gynecologists.
Drug Screen. Retrieved January 15, 2014 from The National Institute on Drug Abuse Web site:
https://nida.nih.gov/
Jones, H.E. et al. (2012). Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction 107. 5-27.
American College of Obstetricians and Gynecologists. (2012). ACOG Committee Opinion 524: Opioid Abuse, Dependence, and Addiction in Pregnancy. Washington, DC: American College of Obstetricians and Gynecologists.
Bandstra, E.S (2010). Prenatal Drug Exposure: Infant and Toddler Outcomes [Electronic Version]. Journal of Addictive Diseases, 29, 245-358.
Kuczkowski, K.M (2007).
The Effects of Drug Abuse on Pregnancy [Electronic Version].
Curr Opin Obstet Gynecol, 19, 578-585.
Brenna, M.W. and Rayburn, W.F. (2012). Counseling about risk of congenital anomalies from prescription opioids. Birth Defects Research 94. 620-625.
Wendell, A.D (2013). Overview and epidemiology of substance abuse in pregnancy. Clinical Obstetrics and Gynecology 56. 91-96.
American Academy of Pediatrics Committee on Drugs (1998). Neonatal Drug Withdrawal [Electronic Version].
Pediatrics, 101:6, 1079-1088.
Return to Women's Health
Return to Substance Use and Abuse
January, 2014
Center_Content